Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | PPARD | Q03181 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.37 |
| ▸ | LTA4H | P09960 | 2/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3680771 | 0.87 | PPARD (0.40) | LMNAL3MBTL1ALDH1A1ACACBPPARG | |
| SCHEMBL196997 | 0.79 | THRB (0.57) | LMNAL3MBTL1ALDH1A1ACACBPPARG | |
| SCHEMBL6562700 | 0.79 | POLB (0.50) | LMNAL3MBTL1ALDH1A1ACACBPPARG | |
| SCHEMBL127434 | 0.79 | CYP3A4 (0.47) | LMNAL3MBTL1ALDH1A1ACACBPPARG | |
| SCHEMBL12994166 | 0.78 | MAPT (0.43) | LMNAL3MBTL1ALDH1A1PPARARECQL | |
| SCHEMBL7650076 | 0.77 | LTA4H (0.46) | LMNAALDH1A1ACACBPPARGPPARD | |
| SCHEMBL5560855 | 0.76 | PPARA (0.41) | LMNAALDH1A1ACACBPPARA | |
| SCHEMBL8385819 | 0.75 | ALDH1A1 (0.39) | LMNAL3MBTL1ALDH1A1ACACBPPARG | |
| SCHEMBL10528978 | 0.74 | THRB (0.56) | ALDH1A1RECQLFFAR1MMP1 | |
| SCHEMBL7764968 | 0.73 | CYP3A4 (0.45) | LMNAL3MBTL1ALDH1A1ACACBPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791289-B2 | Preparation method of copolymerizable photoinitiators | AGFA GRAPHICS NV (BE) | 2014-07-29 | — | — | US | disclosed |
| US-8664431-B2 | Preparation method of copolymerizable photoinitiators | AGFA GRAPHICS NV (BE) | 2014-03-04 | — | — | US | disclosed |
| US-20140024840-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | AGFA GRAPHICS NV (BE) | 2014-01-23 | — | — | US | disclosed |
| US-20100305336-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | AGFA GRAPHICS NV (BE) | 2010-12-02 | — | — | US | disclosed |
| WO-2009068590-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | AGFA GRAPHICS NV (BE) | 2009-06-04 | — | — | WO | disclosed |
| EP-2065362-A1 | Preparation method of copolymerizable photoinitiators | Agfa Graphics N.V. (BE) | 2009-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305336-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | HBB, HBZ, HBG1 | LMNA 412/4885L3MBTL1 935/4885ALDH1A1 390/4885 |
| US-20140024840-A1 | PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS | HBB, HBZ, HBG1 | LMNA 408/4885L3MBTL1 1025/4885ALDH1A1 371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.